Feb 20, 2026High Glycation Burden: Carnosine and Metformin in Clinical ContextLowering glycation burden is mainly a glucose-control and dietary strategy. Carnosine and metformin may support risk reduction in selected contexts, with different evidence depth and safety constraints.
Feb 14, 2026Carnosine: Glycation Buffering, Brain Aging, and Carnosinase VariabilityCarnosine is a dipeptide that buffers glycation and carbonyl stress, with additional evidence for neuroprotection. Oral carnosine is cleaved by carnosinase — tissue uptake varies significantly by carnosinase genotype, which affects individual response.
Jan 23, 2026Blood Sugar and Glycation Management: Berberine, ALA, Chromium, and CarnosineElevated blood glucose accelerates aging through glycation (AGE formation), oxidative stress, and inflammation. Berberine and alpha-lipoic acid have strong glucose-lowering evidence. Carnosine and benfotiamine target the downstream glycation process. A comprehensive protocol addresses multiple pathways.
Jan 17, 2026Beta-Alanine and Carnosine Buffering: Endurance Evidence, Dosing, and Paresthesia ManagementBeta-alanine raises muscle carnosine, a pH buffer that delays fatigue during high-intensity exercise. Evidence is strong for efforts lasting 1-4 minutes. Paresthesia (tingling) is harmless and manageable with split dosing.